Acumetis
  • Home
  • About Us
    • About Us Overview
      • ESG
    • Acumetis Launches as a Single Integrated Brand
  • Expertise
    • Expertise Overview
      • Commercial Strategy
      • Launch Excellence
      • Patient Access & Support Services
      • Global Value & Access
      • Insights & Analytics
      • Medical Affairs
    • Meet Acumetis at Fierce Pharma week 2026
  • Resources
    • Resources Overview
      • Articles
      • Case Study
      • Assessments
      • Policy
      • Trends
    • Implications for Evidence Strategy in Europe
  • Careers
Contact Us
Acumetis
  • Home
  • About Us
    • About Us Overview
      • ESG
    • Acumetis Launches as a Single Integrated Brand
  • Expertise
    • Expertise Overview
      • Commercial Strategy
      • Launch Excellence
      • Patient Access & Support Services
      • Global Value & Access
      • Insights & Analytics
      • Medical Affairs
    • Meet Acumetis at Fierce Pharma week 2026
  • Resources
    • Resources Overview
      • Articles
      • Case Study
      • Assessments
      • Policy
      • Trends
    • Implications for Evidence Strategy in Europe
  • Careers
Contact Us

Case Study
Top down view of a river tributaries on sand
How to achieve HTA submission success for rare disease therapies
A case study illustrating how an evidence‑led, strategically aligned HTA approach can address uncertainty and strengthen submissions for rare disease therapies.
Read More
Articles
Abstract image of different shaped holes in building
Generative AI in publications development: Innovation with oversight
Explore how generative AI can enhance medical publication development with the oversight, rigor, and scientific integrity required by Medical Affairs teams.
Read More
Articles
Doctor showing patient something on a tablet
From approval to patient access: How oncology pharmacy is shaping real-world delivery 
Explore how oncology pharmacy services are shaping real-world delivery and patient access, and why operational readiness is critical beyond HTA approval.
Read More
Articles
Model Builder
Assessing payer ready economic model quality: Acumetis Model Builder vs AI
Can AI support HTA-ready economic models? Compare AI and Model Builder across reproducibility, transparency, and payer readiness.
Read More
Articles
Asembia logo on background
Meet Acumetis at Asembia ASX26
Acumetis (formerly Herspiegel) will be attending Asembia AXS Summit 2026, widely recognized as the epicenter of the specialty pharmacy industry. With more than 8,000 attendees—many of whom are senior decision-makers—Asembia...
Read More
Articles
Zurich MAPS EMEA 2026 logo on background
Meet Acumetis at MAPS EMEA 2026
Meet Acumetis at MAPS EMEA 2026 in Zurich. Connect with our Medical Affairs team and explore approaches to scientific strategy, evidence, and execution.
Read More
Articles
Acumetis logo on background
Acumetis Launches as a Single Integrated Brand to Transform Life Sciences Commercialization
Five leading life sciences organizations - Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group - have come together as a single integrated brand to support better decision-making across...
Read More
Articles
Fierce pharma logo on background
Meet Acumetis at Fierce Pharma week 2026!
Acumetis will be participating in Fierce Pharma Week 2026 in Philadelphia, a large-scale industry event spanning commercialization, marketing, and communications. The event brings together cross-functional leaders to discuss how organizations...
Read More
Case Study
Top down view of a river tributaries on sand
Communication strategy for novel MOA in neurological disorder
To support a novel mechanism of action in a complex neurological indication, Acumetis delivered a focused life sciences commercialization consulting strategy that aligned science, stakeholders, and evidence generation. By integrating...
Read More
1 … 3 4 5 6

Resources

  • Articles
  • Assessments
  • Case Study
  • Policy
  • Resource
  • Trends

Share Our Blog!

Acumetis Logo
Reframe
what's
possible.
Contact Us
Navigation
  • About Us
  • Expertise
  • Careers
  • ESG
  • Privacy Policy
  • Cookies Policy
Copyright © 2026 Acumetis. All rights reserved.